Products

Anti-HLA-B27 Therapeutic Antibody (H4H2499N) (TAB-093CT)

Recombinant monoclonal antibody to HLA-B27. This antibody intended for the prophylaxis and treatment of Ankylosing spondylitis and other spondyloarthropathies.      

Specifications
Immunogen
HLA-B*27 fusion protein (comprising the HLA-B*2705 heavy chain extracellular domain fused to an HLA-restricted peptide and the 132m sequence)
Host
Mouse
Derivation
Hybridoma cell line
Specificity
Human
Species Reactivity
Human
Clone
H4H2499N
Applications
Used for immunoassay techniques such as: Enzyme-linked Immunosorbent Assay; Neutralization; Flow Cytometry
Related Disease
Ankylosing spondylitis and other spondyloarthropathies
Target
Alternative Names
HLA-B27; Human Leukocyte Antigen B27; anti-HLA-B27

For lab research use only, not for diagnostic, therapeutic or any in vivo human use.

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
Send Inquiry Now!
Name:
* Phone:
* E-mail Address:
* Service & Products Interested:
Project Description:
* Verification Code:
Please input "biolabs"(case insensitive) as verification code.
Contact Us to Order
Tel: 1-631-871-5806
Fax: 1-631-207-8356
Email:

45-1 Ramsey Road, Shirley, NY 11967, USA     Tel: 1-631-871-5806    Fax: 1-631-207-8356    Email:
Terms of Service-Privacy Policy     © 2007 - 2017 Creative-Biolabs All Rights Reserved